期刊： HELICOBACTER, 2022; 27 (1)
Background Multiple studies have reported the association between Helicobacter pylori (H. pylori) infection and children's growth. The results of thes......
期刊： HELICOBACTER, 2022; 27 (5)
Background Resistance of Helicobacter pylori (H. pylori) to antibiotics is an evolving and dynamic process. Presence of antibiotic resistance impacts ......
期刊： HELICOBACTER, 2022; 27 (5)
Background The oral cavity is considered a potential reservoir of Helicobacter pylori (H. pylori), and the imbalance of oral microbiota directly refle......
期刊： HELICOBACTER, 2022; 27 (4)
Background About a half of the world's population is infected with Helicobacter pylori (H. pylori), but only 1%-3% of them develop gastric cancer. As ......
期刊： HELICOBACTER, 2022; 27 (4)
Background: Helicobacter pylori (H. pylori) infection and its related diseases are substantial public health burden for highly infected areas. Recentl......
期刊： HELICOBACTER, 2022; 27 (5)
Background: The currently recommended quadruple regimens as rescue therapy on Helicobacter pylori infection were not as effective as being supposed, e......
期刊： HELICOBACTER, 2022; 27 (2)
Background and aims: As with other infectious diseases, Helicobacter pylori eradication regimens should be guided by susceptibility testing to achieve......
期刊： HELICOBACTER, 2022; 27 (2)
Background and objective: The tumor microenvironment and tumor immunity are crucially involved in tumor therapy. Immune checkpoint inhibitors targetin......
期刊： HELICOBACTER, 2022; 27 (2)
Background and Aims: To improve Helicobacter pylori (H. pylori) eradication rate, enhanced patient instructions (EPI) such as telephone-based re-educa......
期刊： HELICOBACTER, 2022; 27 (5)
Background The efficacy and safety of high-dose amoxicillin (AMX) and proton pump inhibitors (PPI) dual therapy raises much more attention in recent y......
期刊： HELICOBACTER, 2022; 27 (1)
Objective In recent years, many studies have tried to prove whether Helicobacter pylori (H. pylori) can promote the progression of atherosclerosis (AS......
期刊： HELICOBACTER, 2022; 27 (2)
Background: The role of H. pylori infection has been reported in various extragastric diseases, particularly, the correlation between H. pylori and at......
期刊： HELICOBACTER, 2022; 27 (6)
Background & Aims Antibiotic resistance of Helicobacter pylori (H. pylori) is increasing worldwide, and bismuth quadruple therapy has been recomme......
期刊： HELICOBACTER, 2022; 27 (3)
Background and aims Previous studies have reported the association between limited number of Helicobacter pylori (H. pylori) antigens and gastric canc......
期刊： HELICOBACTER, 2022; 27 (6)
Background Helicobacter pylori (H. pylori) infection is the main factor leading to some gastric diseases. Currently, H. pylori infection is primarily ......
